Evidence map›Paper›PMID 29530433›Full record

ArticleRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2018

Inter-institutional analysis demonstrates the importance of lower than previously anticipated dose regions to prevent late rectal bleeding following prostate radiotherapy.

Maria Thor, Andrew Jackson, Michael J Zelefsky, Gunnar Steineck, Asa Karlsdòttir, Morten Høyer, Mitchell Liu, Nicola J Nasser, Stine E Petersen, Vitali Moiseenko and 1 more

Abstract read
In one paragraph

Article in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Predictors of prostate bed recurrence on magnetic resonance imaging in patients with rising prostate-specific antigen after radical prostatectomy.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2021
    Article
  4. Review
  5. Article
  6. Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2019
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Maria ThorDept of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, USA. Electronic address: thorm@mskcc.org.
Andrew JacksonDept of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, USA.
Michael J ZelefskyDept of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, USA.
Gunnar SteineckDivision of Clinical Cancer Epidemiology, Dept. of Oncology, Institute of Clinical Sciences, The Sahlgrenska Academy at the University of Gothenburg, Sweden.
Asa KarlsdòttirDept of Oncology, Haukeland University Hospital, Bergen, Norway.
Morten HøyerDept of Oncology, Aarhus University Hospital, Denmark.
Mitchell LiuBritish Columbia Cancer Agency, Vancouver Cancer Center, Canada.
Nicola J NasserDept of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, USA.
Stine E PetersenDept of Oncology, Aarhus University Hospital, Denmark.
Vitali MoiseenkoDept of Radiation, Medicine and Applied Sciences, University of California San Diego, La Jolla, USA.
Joseph O DeasyDept of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

purposeTo investigate whether inter-institutional cohort analysis uncovers more reliable dose-response relationships exemplified for late rectal bleeding (LRB) following prostate radiotherapy. MATERIAL AND

methodsData from five institutions were used. Rectal dose-volume histograms (DVHs) for 989 patients treated with 3DCRT or IMRT to 70-86.4 Gy@1.8-2.0 Gy/fraction were obtained, and corrected for fractionation effects (α/β = 3 Gy). Cohorts with best-fit Lyman-Kutcher-Burman volume-effect parameter a were pooled after calibration adjustments of the available LRB definitions. In the pooled cohort, dose-response modeling (incorporating rectal dose and geometry, and patient characteristics) was conducted on a training cohort (70%) followed by final testing on the remaining 30%. Multivariate logistic regression was performed to build models with bootstrap stability.

resultsTwo cohorts with low bleeding rates (2%) were judged to be inconsistent with the remaining data, and were excluded. In the remaining pooled cohorts (n = 690; LRB rate = 12%), an optimal model was generated for 3DCRT using the minimum rectal dose and the absolute rectal volume receiving less than 55 Gy (AUC = 0.67; p = 0.0002; Hosmer-Lemeshow p-value, p

conclusionWe have demonstrated the importance of integrating datasets from multiple institutions, thereby reducing the impact of intra-institutional dose-volume parameters explicitly correlated with prescription dose levels. This uncovered an unexpected emphasis on sparing of the low to intermediate rectal dose range in the etiology of late rectal bleeding following prostate radiotherapy.

Indexed as

AgedCohort StudiesDose-Response Relationship, RadiationGastrointestinal HemorrhageHumansLogistic ModelsMaleMiddle AgedProstatic NeoplasmsRadiation InjuriesRadiotherapy, ConformalRadiotherapy DosageRectumDose responseGIProstate cancerRadiotherapyRectal bleedingToxicity

Identifiers

PMID29530433
PMCPMC6628908

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.